Increased antimullerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome

Tuesday, March 15, 2016

Authors:
Laura C. Torchen, M.D., Ajay Kumar, Ph.D., Bhanu Kalra, Ph.D., Gopal Savjani, B.S., Ryan Sisk, B.S., Richard S.…

Read More

Dynamic antimullerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes

Thursday, October 29, 2015
The rate of antimullerian hormone decline during controlled ovarian hyperstimulation is associated with ovarian reserve, in vitro fertilization response, and clinical pregnancy, particularly in women older than 35 years of age.

Read More

Two new automated compared with two enzyme linked immunosorbent antimullerian hormone assays

Tuesday, September 29, 2015
New automated AMH assays provide substantially lower values than existing AMH enzyme-linked immunosorbent assays. Assay-specific interpretation is necessary, along with international standardization.

Read More

Antimullerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng mL versus 1 4 ng mL

Tuesday, September 1, 2015
Antimullerian hormone (AMH) levels <1 ng/mL are associated with a statistically significantly lower likelihood of supernumerary good-quality blastocyst cryopreservation as compared with AMH levels between 1 and 4 ng/mL.

Read More

Can highly sensitive antimullerian hormone testing predict failed response to ovarian stimulation

Tuesday, September 1, 2015
Using a cut point of 0.5 ng/mL, antimullerian hormone (AMH) performs well to identify patients at risk of failure of ovarian stimulation for in vitro fertilization. PicoAMH does not provide superior ability to predict failed response.

Read More

Testing and interpreting measures of ovarian reserve A committee opinion

Friday, February 27, 2015

Authors:
Practice Committee of the American Society for Reproductive Medicine

Volume 103, Issue 3, Page e9

Abstract:

Currently there is no uniformly accepted definition of decreased ovarian reserve (DOR), as the term may refer to three related but distinctly different outcomes: oocyte quality, oocyte quantity, or reproductive potential.…

Read More

Association of antimullerian hormone levels with menstrual cycle type and dysmenorrhea in young asymptomatic women

Thursday, July 31, 2014
More-severe menstrual pain is associated with lower antimullerian hormone concentration among Japanese women age 20–22 years who had never used oral contraceptives; the effect persisted even after adjustment for menstrual-cycle regularity.

Read More

Live birth from a 46 year old using fresh autologous oocytes through in vitro fertilization

Wednesday, June 25, 2014
We report a live birth with in vitro fertilization from a 46-year-old woman using autologous oocytes.

Read More

Decline of serum antimüllerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts A prospective cohort study

Friday, January 31, 2014
Bilaterality is the only significant factor in predicting the rate of decline of antim€ullerian hormone levels after laparoscopic ovarian cystectomy.

Read More

Short term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve a pilot randomized controlled trial

Wednesday, November 27, 2013
Salpingectomy at the time of hysterectomy with ovarian preservation does not have any short-term effects on ovarian reserve.

Read More

Age at menarche a predictor of diminished ovarian function

Monday, September 30, 2013
There are significant associations between age at menarche and the risk of diminished ovarian function in infertile women.

Read More

Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle stimulating hormone levels a follow up study

Friday, August 30, 2013
In a prospective cohort study in subfertile women with elevated basal FSH levels, AMH is identified as a marker for actual fertility.

Read More

Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization intracytoplasmic sperm injection

Wednesday, July 31, 2013
We discuss how antimullerian hormone level and antral follicle count are the best predictors for low and excessive responses in women treated with corifollitropin alfa in an antagonist protocol.

Read More

One year followup of serum antimüllerian hormone levels in patients with cystectomy are different sequential changes due to different mechanisms causing damage to the ovarian reserve

Wednesday, July 31, 2013
After cystectomy for endometriomas, the decreased serum antimullerian hormone level can recover; removal of the ovarian cortex may be involved in the ovarian reserve decrease just after surgery.

Read More

Ontogeny of the ovary in polycystic ovary syndrome

Friday, June 28, 2013
Ovarian hyperandrogenism, hyperinsulinemia from insulin resistance, and altered intrafollicular paracrine signaling influence ovarian morphology, follicle survival, and growth as well as oocyte development in women with polycystic ovary syndrome.

Read More

Falsely elevated serum antimüllerian hormone level in a context of heterophilic interference

Tuesday, April 30, 2013
A case of falsely elevated serum AMH level due to heterophilic interference in an infertile 37-year-old woman with rheumatoid arthritis is reported for the first time.

Read More

Antimüllerian hormone levels decrease in women using combined contraception independently of administration route

Thursday, March 28, 2013
In young healthy, normal weight women, continuous use of combined contraception leads to a decrease in serum AMH levels independently of administration route.

Read More

Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization

Monday, March 18, 2013
Some genetic polymorphisms are associated with ovarian response to gonadotropin administration and exhibit potential for a pharmacogenetic approach in ovarian stimulation. In contrast, ovarian reserve seems to be independent of gonadotropin variants.

Read More

Testing and interpreting measures of ovarian reserve A committee opinion

Thursday, November 29, 2012
There is fair evidence against the recommendation that any ovarian reserve test should be used as a sole criterion for the use of ART.

Read More

Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life

Thursday, November 1, 2012
The relationships between primordial follicles, follicular recruitment, and circulating AMH are dynamic, reflecting the different stages of the reproductive lifespan. This article discusses these relationships and their clinical implications.

Read More

Limitations and pitfalls of antimüllerian hormone measurements

Thursday, September 27, 2012
Reflections on "High frequency of discordance between antimullerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers"

Read More

High frequency of discordance between antimullerian hormone and follicle stimulating hormone levels in serum from estradiol confirmed days 2 to 4 of the menstrual cycle from 5354 women in US…

Thursday, September 27, 2012
Frequent discordance was observed between antimullerian hormone and follicle-stimulating hormone, which increased with age in serum from 5,354 women in estradiol-confirmed cycle days 2 to 4.

Read More

Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries

Thursday, June 28, 2012
Antimullerian hormone (AMH) levels correlate independently with polycystic ovaries and ovarian hyperandrogenism. AMH levels in PCOS overlap those in volunteers with normal-variant polycystic ovaries. Only substantial AMH elevations are diagnostic of PCOS.

Read More

Circulating Vitamin D Correlates with Serum Anti-Mullerian Hormone Levels in Late Reproductive-Aged Women: Women’s Interagency HIV Study

Thursday, June 7, 2012
Serum 25-hydroxyvitamin D levels are positively correlated with serum antim€ullerian hormone levels in latereproductive-aged women (40 years old).

Read More

Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters

Monday, June 4, 2012
Lowering of androgens and insulin during pregnancy in mothers with polycystic ovary syndrome reduces anti-Mullerian hormone levels in their daughters, which might reflect a decrease in their follicular mass.

Read More

Impact of cancer therapies on ovarian reserve

Friday, June 1, 2012
Measures of ovarian reserve are impaired among cancer survivors compared with unexposed females of similar age. The degree of impairment is dependent on the toxicity of the previous treatment.

Read More

Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimüllerian hormone levels

Thursday, May 31, 2012
Laparoscopic excision of endometriomas decreases serum AMH levels at 6 weeks and 6 months postoperatively, and the level of decrease is more in cysts that are bilateral or 5 cm.

Read More

Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue

Thursday, May 31, 2012
The follicle pool in transplanted frozen/thawed ovarian tissue is low compared with normal ovaries, and reduced follicular selection may explain these women’s poor reproductive outcomes in assisted reproduction.

Read More

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women

Thursday, May 24, 2012
In 256 young women, serum AMH was found to be applicable in evaluation of the reproductive function. However, hormonal contraceptives may influence the way that AMH levels can be interpreted.

Read More

Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers

Wednesday, May 23, 2012
This study evaluated the association between FSH receptor gene variants and current markers of ovarian reserve. No associations of FSH receptor genotypes with markers of ovarian reserve were detected.

Read More

Translate »